You’ve probably heard a friend or celebrity talk about IV therapy and how they feel amazing after receiving it. But what is ...

Chugai Pharma introduces “Elevidys” as Japan’s first regenerative medical product for Duchenne muscular dystrophy: Tokyo Monday, February 23, 2026, 11:00 Hrs [IST] Chugai Ph ...

Approval expands low-dose MRI contrast options for the youngest patients and reflects a positive benefit–risk profile of ...

Johnson & Johnson (J&J) has reported new findings from the QUASAR long-term extension study of Tremfya (guselkumab) for ...

PDUFA action date set for August 23, 2026 If approved, DTX401 will be the first treatment to address the underlying cause of ...

US FDA accepts for review Dr Reddy’s BLA for proposed interchangeable biosimilar, abatacept: Our Bureau, Bengaluru Monday, February 23, 2026, 12:20 Hrs [IST] Dr Reddy’s Labora ...

Baptist Health is offering eligible patients the option to receive hospital-level care at home through a new program launched at Baptist Medical Center Jacksonville. The program, called Baptist ...

Allspring Premier Large Company Growth Fund lagged its benchmark in Q4 2025 but posted strong yearly gains. Read the full ...

The Allspring Premier Large Company Growth Fund lagged its benchmark in Q4 2025 despite gains from Natera. Read the full analysis for more details.

With Driggs clinic saved from closure, many seek care in Idaho Falls or Jackson as options for vital treatments dwindle.

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...

Background Invasive coronary function testing (CFT) is indicated in patients with refractory angina with non-obstructed coronary arteries (ANOCA). Despite this, questions remain regarding patient ...